Navigation Links
Cardin Calls on NIH to Utilize Small Businesses for Extramural Research Projects
Date:6/22/2009

NIH declines to attend field hearing exploring use of Recovery Act funds

ROCKVILLE, Md., June 22 /PRNewswire-USNewswire/ -- U.S. Senator Benjamin L. Cardin (D-MD), chaired a field hearing today of the U.S. Senate Committee on Small Business and Entrepreneurship in Rockville, MD, entitled "Missed Opportunities: The ARRA and the NIH/SBIR exclusion." During the hearing, local and national experts in biotechnology testified about the important research and development projects that could be funded by the National Institutes of Health (NIH) through the Small Business Innovative Research (SBIR) program, creating jobs and helping to stimulate the economy in Maryland and across the country. Congressman Chris Van Hollen (MD-8) and Congresswoman Donna Edwards (MD-4), who both represent Montgomery and Prince George's Counties, home to numerous biotech and health-related small businesses, participated in the hearing with Senator Cardin.

"With our nation's economy in crisis, Congress moved quickly to enact The American Recovery and Investment Act of 2009 to stimulate our economy to create jobs. One such investment that I strongly supported was additional funding for the National Institutes of Health to conduct biomedical research in areas such as cancer, Alzheimer's, heart disease and stem cell research. I was sorely disappointed though when this NIH funding was exempted from mandatory participation in the SBIR and Small Business Technology Transfer (STTR) programs. As a result, small businesses across the country are being denied the opportunity to receive upwards of $200 million in SBIR and STTR grants.

"The SBIR program is exactly the type of jumpstart that our economy needs during these tough times. Small firms employ 41% of the nation's high-tech workers and generate 13 to 14 times more patents per employee than large firms. The SBIR program alone has generated more than 84,000 patents and millions of jobs. However, despite repeated inquiries, the NIH has yet to provide an adequate response as to how they will ensure that small businesses can receive their fair share of these grants. The SBIR program is especially important because innovation spurs growth and job creation and leads to advanced technology, including life-saving therapies and devices."

The field hearing comes just days after the Senate Committee on Small Business voted to reauthorize the SBIR and STTR programs, which fund more than $2 billion annually in early-stage research and development projects at small technology companies. Eleven federal departments participate in the SBIR program - including the Department of Health and Human Services, the Department of Defense and National Science Foundation - allocating 2.5 percent of their external research and development dollars to the program. Maryland has approximately 440,000 small businesses.


'/>"/>
SOURCE U.S. Senate Committee on Small Business & Entrepreneurship
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Foundation Awards $1 Million to Fund Patient Safety Initiatives
2. Senators Mikulski and Cardin Vote to Protect Americas Kids From Tobacco
3. Cardinal Health Investor and Analyst Advisory
4. Cardinal Health Increases Quarterly Dividend By 25 Percent
5. Cardinal George Praises President Obamas Promise to Support Conscience Clauses, Seeks to Work With Administration on Goal
6. Cardinal Health to Offer Allscripts Electronic Health Record to Solo and Small Physician Groups
7. Cardinal Health Board Proposes Employee Stock Option Exchange Program, Declares Regular Quarterly Dividend
8. Cardinal Health Reports Third Quarter Results
9. The Ohio State University, Cardinal Health, State of Ohio to Invest $10 Million to Advance Medical Imaging Industry
10. Cardinal Rigali Praises House Re-Introduction of Pregnant Women Support Act, Urges Co-Sponsorship
11. Cardinal Rigali Criticizes Draft NIH Guidelines for Destructive Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... A stressful ... at work can also decrease overall productivity and performance in the workplace. The goal ... , During the last few weeks of April, Clearview Resolution Services will be shutting ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... instrument solutions, announces the continuation of its strategic partnership with and platinum sponsorship ... developing nations in the safe and effective management of complex spine deformity cases, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... at the InterContinental Hotel in Boston, Massachusetts ... will present at 11:20 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
Breaking Medicine Technology: